The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: A meta-analysis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Cancer Incidence in Five Continents
(1970) · Springer eBooks · doi:10.1007/978-3-642-85851-2 · Cited by 8,501
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
Self-citationMethods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353
The Risk of Cancer Associated with Specific Mutations of BRCA1 and BRCA2 among Ashkenazi Jews
Struewing, J. P., Hartge, P., Wacholder, S., Baker, S. M., Berlin, M., McAdams, M., Timmerman, M. M., Brody, L. C., & Tucker, M. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199705153362001 · Cited by 2,281
Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229
Risks of cancer in BRCA1-mutation carriers
FORD, D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91578-4 · Cited by 1,850
Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.
Easton, D. F., Ford, D., & Bishop, D. T. (1995) · PubMed Central · Cited by 1,602
Advanced methods in meta‐analysis: multivariate approach and meta‐regression
van Houwelingen, H. C., Arends, L. R., & Stijnen, T. (2002) · Statistics in Medicine · doi:10.1002/sim.1040 · Cited by 1,580
A comparison of methods to detect publication bias in meta‐analysis
Macaskill, P., Walter, S. D., & Irwig, L. (2001) · Statistics in Medicine · doi:10.1002/sim.698 · Cited by 1,286
Key, T. J., Verkasalo, P. K., & Banks, E. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00254-0 · Cited by 1,261
Whittmore, A. S., Harris, R., & Itnyre, J. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116427 · Cited by 1,000
Collaborative Group on Epidemiological Studies of Ovarian Cancer (2008) · The Lancet · doi:10.1016/s0140-6736(08)60167-1 · Cited by 822
Developing Optimal Search Strategies for Detecting Clinically Sound Studies in MEDLINE
Haynes, R. B., Wilczynski, N., McKibbon, K. A., Walker, C. J., & Sinclair, J. C. (1994) · Journal of the American Medical Informatics Association · doi:10.1136/jamia.1994.95153434 · Cited by 765
BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases
Pal, T., Permuth‐Wey, J., Betts, J. A., Krischer, J. P., Fiorica, J., Arango, H., LaPolla, J., Hoffman, M., Martino, M. A., Wakeley, K., et al. (2005) · Cancer · doi:10.1002/cncr.21536 · Cited by 691
Atchley, D. P., Albarracin, C. T., Lopez, A., Valero, V., Amos, C. I., Gonzalez-Angulo, A. M., Hortobagyi, G. N., & Arun, B. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.6231 · Cited by 604
Whittemore, A. S., Harris, R., Itnyre, J., Halpern, J., & the Collaborative Ovarian Cancer Group (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116426 · Cited by 525
Cancer Risks in Two Large Breast Cancer Families Linked to BRCA2 on Chromosome 13q12‐13
Easton, D. F., Steele, L., Fields, P., Ormiston, W., Averill, D., Daly, P. A., McManus, R., Neuhausen, S. L., Ford, D., Wooster, R., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/513891 · Cited by 387
Modan, B., Hartge, P., Hirsh-Yechezkel, G., Chetrit, A., Lubin, F., Beller, U., Ben-Baruch, G., Fishman, A., Menczer, J., Struewing, J. P., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107263450401 · Cited by 385
Sterne, J. A. C., Jüni, P., Schulz, K. F., Altman, D. G., Bartlett, C., & Egger, M. (2002) · Statistics in Medicine · doi:10.1002/sim.1184 · Cited by 382
Oral Contraceptives and the Risk of Breast Cancer in BRCA1 and BRCA2 Mutation Carriers
Narod, S. A. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.23.1773 · Cited by 380
BRCA1 and BRCA2 Mutation Analysis of 208 Ashkenazi Jewish Women with Ovarian Cancer
Moslehi, R., Chu, W., Karlan, B., Fishman, D., Risch, H., Fields, A., Smotkin, D., Ben-David, Y., Rosenblatt, J., Russo, D., et al. (2000) · The American Journal of Human Genetics · doi:10.1086/302853 · Cited by 314
Caro, J. J., Johannes, C. B., Hartz, S. C., Marrs, R., & Miettinen, O. S. (1993) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116754 · Cited by 288
Risk Factors for Triple-Negative Breast Cancer in Women Under the Age of 45 Years
Dolle, J. M., Daling, J. R., White, E., Brinton, L. A., Doody, D. R., Porter, P. L., & Malone, K. E. (2009) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-1005 · Cited by 271
A sensitivity analysis for publication bias in systematic reviews
Copas, J. B., & Shi, J. Q. (2001) · Statistical Methods in Medical Research · doi:10.1177/096228020101000402 · Cited by 259
McLaughlin, J. R., Risch, H. A., Lubinski, J., Moller, P., Ghadirian, P., Lynch, H., Karlan, B., Fishman, D., Rosen, B., Neuhausen, S. L., et al. (2007) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70983-4 · Cited by 247
Hormonal aspects of epithelial ovarian cancer: review of epidemiological evidence
Riman, T., Persson, I., & Nilsson, S. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00577.x · Cited by 199
Ursin, G., Henderson, B. E., Haile, R. W., Pike, M. C., Zhou, N., Diep, A. T., & Bernstein, L. (1997) · PubMed · Cited by 182
Taking advantage of the explosion of systematic reviews: an efficient MEDLINE search strategy.
Shojania, K. G., & Bero, L. A. (2001) · PubMed · Cited by 176
Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 or BRCA2 mutations
Whittemore, A. S., Balise, R. R., Pharoah, P. D. P., DiCioccio, R. A., Oakley-Girvan, I. A., Ramus, S. J., Daly, M. B., Usinowicz, M. B., Garlinghouse-Jones, K., Ponder, B. A. J., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602239 · Cited by 152
Brohet, R. M., Goldgar, D. E., Easton, D. F., Antoniou, A. C., Andrieu, N., Chang-Claude, J. C., Peock, S., Eeles, R. A., Cook, M., Chu, C., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.1179 · Cited by 151
Antoniou, A. C., Rookus, M. A., Andrieu, N., Brohet, R. M., Chang-Claude, J. C., Peock, S., Cook, M., Evans, D. G., Eeles, R. A., EMBRACE, et al. (2009) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0546 · Cited by 143
Self-citationBRCA1 and BRCA2 Mutation Carriers, Oral Contraceptive Use, and Breast Cancer Before Age 50
Haile, R. W., Thomas, D. C., McGuire, V. M., Felberg, A., John, E. M., Milne, R. L., Hopper, J. L., Jenkins, M. A., Levine, A. J., Daly, M. M., et al. (2006) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-06-0258 · Cited by 123
Gronwald, J., Byrski, T., Huzarski, T., Cybulski, C., Sun, P., Tulman, A., Narod, S. A., & Lubiński, J. (2005) · Breast Cancer Research and Treatment · doi:10.1007/s10549-005-9051-5 · Cited by 99
Lee, E., Ma, H., McKean‐Cowdin, R., Berg, D. V. D., Bernstein, L., Henderson, B. E., & Ursin, G. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-08-0396 · Cited by 97
BRCA1 and implications for response to chemotherapy in ovarian cancer
Quinn, J. E., Carser, J., James, C. R., Kennedy, R. D., & Harkin, D. P. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.12.015 · Cited by 76
Genetic heterogeneity of breast-ovarian cancer revisited. Breast Cancer Linkage Consortium.
Narod, S. A., Ford, D., Devilee, P., Barkardottir, R. B., Eyfjord, J. E., Lenoir, G., Serova, O., Easton, D. F., & Goldgar, D. E. (1995) · Europe PMC (PubMed Central) · Cited by 75
Jernström, H., Loman, N., Johannsson, O. T., Borg, Å., & Olsson, H. L. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.03.035 · Cited by 71
A sensitivity analysis for publication bias in systematic reviews
Copas, J. B., & Shi, J. (2001) · Statistical Methods in Medical Research · doi:10.1191/096228001678227776 · Cited by 60
Oral contraceptives and risk of familial breast cancer
Heimdal, K., Skovlund, E., & Møller, P. (2002) · Cancer Detection and Prevention · doi:10.1016/s0361-090x(02)00004-1 · Cited by 58
Runnebaum, I. B., Wang‐Gohrke, S., Vesprini, D., Kreienberg, R., Lynch, H. T., Moslehi, R., Ghadirian, P., Weber, B., Godwin, A. K., Risch, H. A., et al. (2001) · Pharmacogenetics · doi:10.1097/00008571-200110000-00010 · Cited by 51
Hormone replacement therapy is more prevalent among Jewish BRCA1/2 mutation carriers
Bruchim, R. B.-S., Chetrit, A., Figer, A., Papa, M. Z., Flex, D., Rizel, S., & Friedman, E. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2005.08.045 · Cited by 14
Explaining heterogeneity in meta-analysis: a comparison of methods
Thompson, S. G., & Sharp, S. J. (1999) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19991030)18:20
Cited by
Daly, M. B., Pal, T., Berry, M. P., Buys, S. S., Dickson, P., Domchek, S. M., Elkhanany, A., Friedman, S., Goggins, M., Hutton, M. L., et al. (2021) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2021.0001 · Cited by 1,112
Epidemiology of epithelial ovarian cancer
Webb, P. M., & Jordan, S. J. (2017) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2016.08.006 · Cited by 995
Genetic/Familial High-Risk Assessment: Breast and Ovarian
Daly, M. B., Axilbund, J. E., Buys, S., Crawford, B., Farrell, C. D., Friedman, S., Garber, J. E., Goorha, S., Gruber, S. B., Hampel, H., et al. (2010) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2010.0043 · Cited by 646
Caruso, G., Weroha, S. J., & Cliby, W. (2025) · JAMA · doi:10.1001/jama.2025.9495 · Cited by 304
Ovarian Cancer Prevention and Screening
Menon, U., Karpinskyj, C., & Gentry-Maharaj, A. (2018) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002580 · Cited by 279
Metadata
- Authors
- Iodice, S., Barile, M., Rotmensz, N., Feroce, I., Bonanni, B., Radice, P., Bernard, L., Maisonneuve, P., & Gandini, S.
- Venue
- European Journal of Cancer
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 46
- Issue
- 12
- Pages
- 2275-2284
- ISSN
- 0959-8049 (ISSN-L)
- OpenAlex
- W2061635845
- Cited by
- 281
- References
- 46
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.